WeightWatchers introduced its partnership with Personify Well being to permit employers to supply the corporate’s enterprise options to assist staff entry weight-related healthcare choices, together with behavioral well being, medicine administration and digital care.
WeightWatchers for Enterprise affords applications centered on altering habits, together with applications tailor-made for people with diabetes or these on GLP-1 drugs. The corporate additionally affords digital medical care and medicine administration, group boards, teaching help, and well being knowledge and analytics.
Personify Well being, which is the results of a $3 billion merger between Virgin Pulse’s employee-wellness and engagement firm and HealthComp’s well being plan-administration group, affords one platform with well being, navigation, advantages and wellbeing experiences, alongside data-driven personalization.
Corporations utilizing Personify Well being may have the choice to supply their staff WeightWatchers for Enterprise to entry the burden loss corporations B2B choices.
“We’re grateful for our partnership with Personify Well being and proud to work alongside them as some of the revolutionary leaders within the trade,” Rémi Cossart, head of WeightWatchers Clinic and WeightWatchers for Enterprise, stated in a press release.
“We perceive the significance of weight well being care and the wants of organizations, and are excited to open up entry to Personify Well being’s community to assist eradicate weight bias, maximize customized well being outcomes, and guarantee high quality care.”
THE LARGER TREND
Virgin Pulse and HealthComp rebranded as Personify Well being in February combining the businesses choices.
The variety of digital well being corporations providing platforms centered on GLP-1 drugs has elevated this 12 months.
Final month, meals and vitamin app MyFitnessPal launched new choices and content material to assist members taking GLP-1s maximize their nutrient consumption whereas having access to recipes, group boards and medicine monitoring.
In January, digital weight reduction firm Noom introduced its business enterprise, Noom for Work, would associate with Liviniti, a nationwide pharmacy profit supervisor. Collectively, the pair would provide plan sponsors and their staff a digital GLP-1 Companion for continual weight situations.
Buyers additionally see the promise of GLP-1s in making an affect on affected person weight reduction, together with Andreesseen Horowitz funding associate Jay Rughani whom spoke to MobiHealthNews on the topic in December and managing director at Normal Catalyst Holly Maloney who joined the publication to debate the rise in adoption of GLP-1s in January.